Adult-onset Still’s disease: a report of 28 cases and review of the literature

References

• Bywaters EG. Still's disease in the adult. Ann Rheum Dis. 1971;30:121.
   PubMed Web of Science ®Google Scholar
• Bannatyne GA, Wohlmann AS. Rheumatoid arthritis: its clinical history, etiology and pathology. Lancet. 1896;1:1120–5.
   Google Scholar
• Meijvis SC, Endeman H, Geers AB, ter Borg EJ. Extremely high serum ferritin levels as diagnostic tool in adult-onset Still's dis-ease. Neth J Med. 2007;65(6):212–4.
   Google Scholar
• Larson EB. Adult Still's disease: recognition of a clinical syn-drome and recent experience. West J Med. 1985;142(5):665–71.
   PubMedGoogle Scholar
• Rheumatic diseases, John J. Cush, Arthur Kavanaugh, C. Michael Stein. Rheumatology Diagnosis and Therapies, 2nd edn. Phila-delphia: Lippincott, Baltimore: Williams and Wilkins; 2005. p. 110–2.
   Google Scholar
• Cagatay Y, Gul A, Cagatay A, Karnali S, Karadeniz A, Inane M, Ocal L, Aral 0, Konice M. Adult- onset Still's disease. Int J Clin Pract. 2007;1-6, Published Online: 18 May 2007.
   Google Scholar
• Pouchot J, Sampalis JS, Beaudet F, et al. Adult-onset Still's disease: manifestations, disease course and outcome in 62 patients. Medicine (Baltimore). 1991;70:118.
   PubMed Web of Science ®Google Scholar
• Edward D, Harris JR. Clinical features of rheumatoid arthritis, Kelley's textbook of rheumatology, 7th edn. Saunders: Elsevier; 2005. p. 1047–8.
   Google Scholar
• Chen DY, Lan JL, Hsieh TY, Chen YH. Clinical manifestations, disease course, and complications of adult-onset Still's disease in Taiwan. J Formos Med Assoc. 2004;103(11):844–52.
   Google Scholar
• Wouters JM, Van de putte LB. Adult-onset Still's disease: clinical and laboratory features, treatment and progress of 45 cases. Q J Med. 1986;61:1055–6.
   PubMedGoogle Scholar
• Kelly J, Chowienczyk P, Gibson T. Sore throat and hyperferri-tinaemia. J R Soc Med. 2001;94:400–1.
   Google Scholar
• Nguyen KH, Weisman MH. Severe sore throat as a presenting symptom of adult-onset Still's disease: a case series and review of the literature. J Rheumatol. 1997;24:592.
   Google Scholar
• Chen DY, Lan HH, Hsieh TY, Chen HH, Lan JL. Crico-thyroid perichondritis leading to sore throat in patients with active adult-onset Still's disease. Ann Rheum Dis. 2007;66(9):1264–6.
   Google Scholar
• Bambery P, Thomas RJ, Malhotra HS, Kaur U, Bhusnurmath SR, Deodhar SD. Adult-onset Still's disease: clinical experience with 18 patients over 15 years in northern India. Ann Rheum Dis. 1992;51:529–32.
   Google Scholar
• Mert A, Ozaras R, Tabak F, Bilir M, Ozturk R, Ozdogan H, et al. Fever of unknown origin: a review of 20 patients with adult-onset Still's disease. Clin Rheumatol. 2003;22(2):89–93.
   Google Scholar
• Tabak F, Mert A, Celik AD, et al. Fever of unknown origin in Turkey. Infection. 2003;31:417–20.
   PubMed Web of Science ®Google Scholar
• Crispin JC, Martinez-Banos D, Alcocer-Varela J. Adult-onset Still disease as the cause of fever of unknown origin. Medicine (Baltimore). 2005;84(6):331–7.
   PubMed Web of Science ®Google Scholar
• Owlia MB. Clinical spectrum of connective tissue disorders. JI-ACM. 2006;7(3):217–24.
   Google Scholar
• Prendiville JS, Tucker LB, Cabral DA, Crawford RI. A pruritic linear urticarial rash, fever, and systemic inflammatory disease in five adolescents: adult-onset Still disease or systemic juvenile idiopathic arthritis sine arthritis? Pediatr Dermatol. 2004;21(5):580–8.
   Google Scholar
• Affleck AG, Littlewood SM. Adult-onset Still's disease with atypical cutaneous features. J Eur Acad Dermatol Venereol. 2005;19(3):360–3.
   Google Scholar
• Kaur S, Bambery P, Dhar S. Persistent dermal plaque lesions in adult-onset Still's disease. Dermatology. 1994;188(3):241–2.
   Google Scholar
• Thien Huong NT, Pitche P, Minh Hoa T, Laurent R. Persistent pigmented plaques in adult-onset Still's disease. Ann Dermatol Venereol. 2005;132:693–6.
   Google Scholar
• Fernandez-Guarino M, Gonzalez C, Bardal Ruiz A, Calvo Pufido M, Harto Castaiio A, Jaen Olasolo P. Adult Still's disease with atypical skin manifestations. Actas Dermosifiliogr. 2006;97(9):591–3.
   Google Scholar
• Criado RF, Criado PR, Vasconcellos C, Szajubok JC, Michalany NS, Kadunc BV, et al. Urticaria as a cutaneous sign of adult-onset Still's disease. J Cutan Med Surg. 2006;10(2):99–103.
   Google Scholar
• Lee JB, Kim JW, Lee SS, Kim SJ, Won YH, Lee SC. Adult-onset Still's disease with vesiculopustules on the hands and feet. J Korean Med Sci. 2002;17(6):852–5 12483016.
   Google Scholar
• Grattan CEH, Kobza Black A. Urticaria and mastocytosis. In: Burns T, Breathnach S, Cox N, Griffiths C. Rook's textbook of dermatology, vol. 47. 7th edn. Oxford: Blackwell; 2004. p. 17–8.
   Google Scholar
• Ta§kapan 0, Harmanyeri Y. Evaluation of patients with symp-tomatic dermographism. J Eur Acad Dermatol Venereol. 2006;20(1):58–62.
   Google Scholar
• Adcock BB, Hornsby LB, Jenkins K. Dermographism: an adverse effect of atorvastatin. J Am Board Fam Pract. 2001;14(2):148–51.
   Google Scholar
• Fautrel B, Zing E, Golmard JL, Le Moel G, Bissery A, Rioux C, et al. Proposal for a new set of classification criteria for adult-onset Still's disease. Medicine (Baltimore). 2002;81:194–200.
   Google Scholar
• Appenzeller S, Castro GR, Costallat LT, Samara AM, Bértolo MB. Adult-onset Still's disease in southeast Brazil. J Clin Rheumatol. 2005;11(2):76–80.
   Google Scholar
• Chandran V, Aggarwal A, Misra R. Adult-onset Still's disease. J Indian Rheumatol Assoc. 2002;10:19–21.
   Google Scholar
• Owlia MB, Soleimani H, Haji Ghasemian SH. Adult-onset Still's disease presenting first in pregnancy (case report). J Shahid Sa-doughi University of Medical Sciences. 2003;11(2):67–70.
   Google Scholar
• Singh S, Samant R, Joshi VR. Adult-onset Still's disease: a study of 14 cases. Clin Rheumatol. 2008;27(1):35–9.
   Google Scholar
• Van Reeth C, Le Moel G, Revenant Lasne Y, Agneray MC, Kahn MF J, Bourgeois P. Serum ferritin and isoferritins are tools for diagnosis of active adult Still's disease. J Rheumatol. 1994;21(5): 890–5.
   Google Scholar
• Fautrel B, Le Moel G, Saint-Marcoux B, Taupin P, Vignes S, Rozenberg S, et al. Diagnostic value of fenitin and glycosylated fenitin in adult-onset Still's disease. J Rheumatol. 2001;28: 322–9.
   Google Scholar
• Vignes S, Le Moel G, Fautrel B, Wechsler B, Godeau P, Piette JC. Percentage of glycosylated serum fenitin remains low throughout the course of adult-onset Still's disease. Ann Rheum Dis. 2000;59:347–50.
   PubMed Web of Science ®Google Scholar
• Owlia MB, Soleimani H, Mortazavizadeh MR. Macrophage Activation Syndrome (MAS) and Thrombotic Thrombocytopenic Purpura (TTP)-Are they from a single spectrum? JIACM. 2005;6(4):337–40.
   Google Scholar
• Kadar J, Petrovicz E. Adult-onset Still's disease. Best Pract Res Clin Rheumatol. 2004;18:663–76.
   PubMed Web of Science ®Google Scholar
• Kraetsch HG, Antoni C, Kalden JR, Manger B. Successful treatment of a small cohort of patients with adult-onset of Still's disease with infliximab: first experiences. Ann Rheum Dis. 2001;60 :iii55–7.
   Google Scholar
• Kurasawa M, Kotani K, Kurasawa G, Shida K, Yamada S, Tago T. Adult-onset Still's disease in a patient over 80 years old suc-cessfully treated with low-dose methotrexate therapy. Age Ageing. 2007;36(1):104–6.
   PubMed Web of Science ®Google Scholar
• Lopez Rodriguez M, Garcia Arias M, Gomez Cerezo. Biological therapy with anti-TNF antibodies. Extending the spectrum of its indications? J Rev Clin Esp. 2007;207(9):448–50.
   Google Scholar
• Efthimiou P, Kontzias A, Ward CM, Ogden NS. Adult-onset Still's disease: can recent advances in our understanding of its pathogenesis lead to targeted therapy? Nat Clin Pract Rheumatol. 2007;3(6):328–35.
   PubMedGoogle Scholar
• Furst DE, Breedveld FC, Kalden JR, Smolen JS, Burmester GR, Sieper J, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007. Ann Rheum Dis. 2007;66(3):iii2–22.
   Google Scholar
• Efthimiou P, Markenson JA. Role of biological agents in immune-mediated inflammatory diseases. South Med J. 2005;98: 192–204.
   PubMedGoogle Scholar
• Cavagna L, Caporali R, Epis 0, Bobbio-Pallavicini F, Monte-cucco C. Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol. 2001;19: 329–32.
   Google Scholar
• Kokkinos A, Iliopoulos A, Greka P, Efthymiou A, Katsilambros N, Sfikakis PP. Successful treatment of refractory adult-onset Still's disease with infliximab. A prospective, non-comparative series of four patients. Clin Rheumatol. 2004;23:45–9.
   Google Scholar
• Olivieri I, de Stefano G, Padula A, La Gala A, de Stefano C. Infliximab in a case of early adult-onset Still's disease. Clin Rheumatol. 2003;22:369–70.
   Google Scholar
• Thonhofer R, Soleiman A, Kriessmayr M, Thonhofer U, Wipfler E, Gaugg M, et al. Decrease of proteinuria in a patient with adult-onset Still's disease and glomerulonephritis after anti-TNFalpha therapy. Scand J Rheumatol. 2006;35(6):485–8.
   Web of Science ®Google Scholar
• Husni ME, Maier AL, Mease PJ, Overman SS, Fraser P, Gra-vallese EM, et al. Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum. 2002;46:1171–6.
   Google Scholar
• Kuek A, Weerakoon A, Ahmed K, Ostor AJ. Adult-onset Still's disease and myocarditis: successful treatment with intravenous immunoglobulin and maintenance of remission with etanercept. Rheumatology (Oxford). 2007;46(6):1043–4.
   Google Scholar
• Kumari R, Uppal SS. Prolonged remission in adult-onset Still's disease with etanercept. Clin Rheumatol. 2006;25(1):106–8.
   Google Scholar
• Asherson RA, Pascoe L. Adult-onset Still's disease: response to Enbrel. Ann Rheum Dis. 2002;61:859–60.
   PubMedGoogle Scholar
• Senatrice J, Granel B, Disdier P, Weiller PJ, Dussol B. Resolu-tion with etanercept of nephrotic syndrome due to renal AA amyloidosis in adult Still's disease. Am J Med. 2003;115:589–90.
   Google Scholar
• Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA. Rapid responses to anakinra in patients with refractory adult-onset Still's disease. Arthritis Rheum. 2005;52(6):1794–803.
   Google Scholar
• Kötter I, Wacker A, Koch S, Henes J, Richter C, Engel A, et al. Anakinra in Patients with Treatment-Resistant Adult-Onset Still's Disease: Four Case Reports with Serial Cytokine Measurements and a Review of the Literature. Semin Arthritis Rheum. 2007;37(3):189–97 (Epub 2007 Jun 20).
   Google Scholar
• Quartuccio L, De Vita S. Interleukin 1 receptor antagonist ther-apy-induced thrombocytopenia in adult-onset Still's disease. J Rheumatol. 2007;34(4):892–3.
   Google Scholar
• Godinho F, Santos MJ, Canas Da Silva J. Refractory adult-onset Still's disease successfully treated with anakinra. Ann Rheum Dis. 2005;64:647–8.
   Google Scholar
• Ahmadi-Simab K, Lamprecht P, Jankowiak C, Gross WL. Suc-cessful treatment of refractory adult-onset Still's disease with rituximab. Ann Rheum Dis. 2006;65(8):1117–8.
   Google Scholar